Immix Biopharma Subsidiary Nexcella Appoints Edward J. Borkowski, former Chief Financial Officer of Mylan N.V, to Board of Directors

Mr. Borkowski joins the Nexcella, Inc. Board of Directors with more than 30 years of experience in the pharmaceutical and healthcare industry, including 7 years as Chief Financial Officer of Mylan N.V. Mr. Borkowski is also the former Chief Financ...

Related Keywords

Los Angeles ,Gabriel Morris ,Edwardj Borkowski ,Carl Icahn ,Alex Lobo ,Ilya Rachman ,Advanz Pharma ,Immix Biopharma Inc ,Company Contact ,Nexcella Inc ,Amerigen Pharmaceuticals ,Trustee Of Allegheny College ,Immix Biopharma Inc Nasdaq ,Pfizer ,Exchange Commission ,Becton Dickinson ,Company Board Of Directors ,Rutgers University ,Allegheny College ,Chief Financial Officer ,Immix Biopharma ,Executive Vice President ,Nexcella Board ,Chief Executive Officer ,Concordia Healthcare ,American Home Products ,Political Science ,Tissue Specific Therapeutics ,Orphan Drug Designation ,Rare Pediatric Disease Designation ,Risk Factor ,Annual Report ,Markets ,